Paper41428107
A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas.
Zhou Y and 3 others. Discov Oncol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas. Papers, record 41428107. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41428107
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35468964 | HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. | Nat Genet | 2022 | https://conductscience.org/library/papers/35468964 | PubMed |
| 2 | 29643471 | Current state of immunotherapy for glioblastoma. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29643471 | PubMed |
| 3 | 31126321 | Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. | Genome Med | 2019 | https://conductscience.org/library/papers/31126321 | PubMed |
| 4 | 26516226 | Immunosuppressive mechanisms in glioblastoma. | Neuro Oncol | 2015 | https://conductscience.org/library/papers/26516226 | PubMed |
| 5 | 35877357 | Effects and Prognostic Values of Circadian Genes CSNK1E/GNA11/KLF9/THRAP3 in Kidney Renal Clear Cell Carcinoma via a Comprehensive Analysis. | Bioengineering (Basel) | 2022 | https://conductscience.org/library/papers/35877357 | PubMed |
| 6 | 39248287 | EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/39248287 | PubMed |
| 7 | 36920044 | Circular RNA ACACA negatively regulated p53-modulated mevalonate pathway to promote colorectal tumorigenesis via regulating miR-193a/b-3p/HDAC3 axis. | Mol Carcinog | 2023 | https://conductscience.org/library/papers/36920044 | PubMed |
| 8 | 16199517 | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16199517 | PubMed |
| 9 | 33264103 | TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/33264103 | PubMed |
| 10 | 39098678 | Biohybrid hydrogel inhibiting β-klotho/HDAC3 axis for hepatocellular carcinoma treatment. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/39098678 | PubMed |
| 11 | 24083766 | Lgr4 promotes glioma cell proliferation through activation of Wnt signaling. | Asian Pac J Cancer Prev | 2013 | https://conductscience.org/library/papers/24083766 | PubMed |
| 12 | 10592173 | KEGG: kyoto encyclopedia of genes and genomes. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592173 | PubMed |
| 13 | 32442275 | TIMER2.0 for analysis of tumor-infiltrating immune cells. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/32442275 | PubMed |
| 14 | 25485508 | Loss of circadian clock gene expression is associated with tumor progression in breast cancer. | Cell Cycle | 2014 | https://conductscience.org/library/papers/25485508 | PubMed |
| 15 | 36683050 | Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36683050 | PubMed |
| 16 | 32398667 | Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32398667 | PubMed |
| 17 | 24789043 | Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells. | PLoS One | 2014 | https://conductscience.org/library/papers/24789043 | PubMed |
| 18 | 18976072 | Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. | J Neurosurg | 2008 | https://conductscience.org/library/papers/18976072 | PubMed |
| 19 | 15737082 | Survival model predictive accuracy and ROC curves. | Biometrics | 2005 | https://conductscience.org/library/papers/15737082 | PubMed |
| 20 | 23254314 | Circadian gene expression and clinicopathologic correlates in pancreatic cancer. | J Gastrointest Surg | 2013 | https://conductscience.org/library/papers/23254314 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41428107
GET https://conductscience.org/api/papers/v1/41428107/references?page=2